威门药业 (430369.OC)

+ 收藏

财务分析(报告期)(威门药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 137,366,001.29390,370,927.30138,616,220.47510,695,090.57320,300,868.84187,947,333.3460,309,043.22
 营业利润(元) 13,047,597.5219,138,621.483,971,821.1275,226,254.6948,619,558.7922,674,076.98-7,600,781.25
 利润总额(元) 6,098,298.3519,196,704.023,978,820.0174,687,541.9548,044,814.0022,334,832.39-7,732,762.33
 净利润(元) 1,883,659.6319,135,869.322,169,527.4861,291,017.8439,114,588.6518,137,824.50-8,122,852.20
 归属于母公司股东的净利润(元) 1,883,659.6319,135,869.322,169,527.4861,291,017.8439,114,588.6518,137,824.50-8,122,852.20
盈利能力:
 销售毛利率(%) 76.7476.1275.2779.1879.3478.4779.48
 销售净利率(%) 1.374.901.5712.0012.219.65-13.47
 净资产收益率(%) 0.343.410.39----
 总资产报酬率ROA(%) 1.001.720.62----
 投入资本回报率ROIC(%) 0.552.010.468.575.522.27-0.91
营运能力:
 存货周转率(次) 0.150.560.22----
 应收账款周转率(次) 0.671.400.63----
 总资产周转率(次) 0.160.440.16----
偿债能力:
 资产负债率(%) 32.1535.2035.5938.7235.0034.5235.38
 股东权益比率(%) 67.8564.8064.4161.2865.0065.4864.62
 已获利息倍数(倍) 3.64-3.904.0445.03138.17-14.83-4.06
 流动比率 2.672.382.292.072.252.332.34
 速动比率 1.281.591.431.571.551.651.62
发展能力:
 营业收入增长率(%) -0.90-23.56-26.254.9811.838.75-6.31
 营业利润增长率(%) 228.50-74.56-82.4842.4548.060.75-1,309.32
 税后利润增长率(%) -13.18-68.78-88.0457.9379.2117.09-2,263.74
 净资产增长率(%) 1.593.47-0.90-0.29-4.86-
 总资产增长率(%) -3.55-2.140.742.59-2.55-

前瞻产业研究院